Release Summary

Inspiration Biopharmaceuticals Highlights Positive Interim Data on its Two Lead Investigational Product Candidates in hemophilia: Recombinant Porcine FVIII (OBI-1) and Recombinant Factor IX (IB1001)

Inspiration Biopharmaceuticals, Inc.